Cardinal Health, Inc

Industry: Biotechnology Drugs

Fortune Rank: 17

CAH is a holding company that provides products and services to healthcare providers and manufacturers to help them improve the efficiency and quality of healthcare. For the FY ended 6/30/05, revenues rose 15% to $74.91B. Net income from cont. ops. and before acct. chg. fell 31% to $1.05B. Revenues reflect continued growth in the Medical Products & Services segment. Net income was offset by higher SG&A expenses and increased restructuring charges.

Cardinal Health, Inc. is a holding company that owns operating subsidiaries conducting business as Cardinal Health. The Company is a provider of products and services supporting the healthcare industry. The Company's operations are organized into four segments: Pharmaceutical Distribution and Provider Services; Medical Products and Services; Pharmaceutical Technologies and Services, and Clinical Technologies and Services.

Cardinal Health, Inc

Cardinal Health, Inc is a Fortune 500 company. In 2010 Cardinal Health, Inc was ranked number 17 on the Fortune 500 list, making it the 17th largest company in the United States when judged by revenue.

Cardinal Health, Inc achieved revenue of $99,612.90 million in 2010 and earned a profit of $1,151.60 million.

Cardinal Health, Inc' rank improves

The company ranking improved in 2010, moving up the Fortune 500 list to 17th compared to 18th in 2009. This was based on its 2009 revenue of $91,091 million (a change of 8 million compared to 2010) and profits of $1,301 million (a change of $0 million compared to 2009).

Another point of view

To many investors, profits are more important than the revenue a company earns. If the Fortune 500 was ranked by profits instead of revenue then Cardinal Health, Inc would be ranked 114th rather than 17th due to its profits of $1,152 in 2010.

Cardinal Health, Inc Revenue* Profit* Fortune Ranking

* US$ Million

USPages Latest Business News At A Glance Business Shortcuts